Medtronic plc, a global leader in healthcare technology, announced the United States Food and Drug Administration (FDA) has approval of the Affera Mapping and Ablation System with Sphere-9 catheter, ...

Medtronic has announced that the US Food and Drug Administration (FDA) has approved the Affera mapping and ablation system featuring the Sphere-9 Catheter. This innovative, all-in-one system ...

GALWAY, Ireland - Medtronic plc (NYSE:MDT), a global healthcare technology leader, announced today that it has received FDA approval for its Affera Mapping and Ablation System with Sphere-9 Catheter.

For more information on Affera and the Sphere-9 catheter, visit Medtronic.com. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic’s periodic ...

October 25, 2024—Vantis Vascular, Inc. announced it has received FDA 510(k) clearance for its CrossFast integrated microcatheter guide extension system ... that couples the outer and inner extension ...

The Affera Mapping and Ablation System and Sphere-9 catheter also received CE Mark in March 2023 and was approved in Australia in September 2024. In October 2024, Medtronic announced the start of ...

For more information on Affera and the Sphere-9 catheter, visit Medtronic.com. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's ...